NUST Institutions Library Catalogue Search for 'kw,wrdl: (su-br:"Depression, Mental")'

Evidence-based psychotherapies for children and adolescents /

New York : Guilford Press, 2010 . xx, 602 p. : 26 cm.. 9781593859749 (hardcover : alk. paper) | 1593859740 (hardcover : alk. paper)

Place Hold on Evidence-based psychotherapies for children and adolescents /

Handbook of assessment and treatment planning for psychological disorders /

New York : Guilford Press, 2010 . xiv, 706 p. ; 27 cm.. 9781606238684 (hardcover : alk. paper) | 160623868X (hardcover : alk. paper)

Place Hold on Handbook of assessment and treatment planning for psychological disorders /

Oxford textbook of psychopathology /

New York : Oxford University Press, 2009 . xii, 826 p. : 26 cm.. 9780195374216 (cloth : alk. paper) | 0195374215 (cloth : alk. paper)

Place Hold on Oxford textbook of psychopathology /

A first-rate madness : uncovering the links between leadership and mental illness /

By Ghaemi, S. Nassir.. New York : Penguin Press, 2011 . 340 p. ; 25 cm.. 9781594202957 (hardback) | 1594202958 (hardback)

Place Hold on A first-rate madness :

How to change your mind : what the new science of psychedelics teaches us about consciousness, dying, addiction, depression, and transcendence

By Pollan, Michael,. New York : Penguin Press, 2018 . xii, 465 pages ; 25 cm. 9781594204227 (hardback) | 1594204225 (hardback) | 9780735224155 (paperback)

Place Hold on How to change your mind :

Oral Administration of Fluoxetine Incorporated Liposomal Nanoparticles coated with PEG in Treatment of Chronic Mild stress (CMS) /

By Sadiq, Nadia . . 55p. , Depression is one of the most increasing psychological mood disorders, depression does not have some specific physical symptoms, but it negatively affects the person mood, way of living and thinking chronic mild stress (CMS) is one of its type, depression is affecting more than 300million people in the world. Shortness of breath, headache, being miserable, stomach disturbance and physical tensions are some of the common symptoms of depression that is reported according to National Alliance of Mental Health, Anti-depressant are used for altering the neurotransmitters those are serotonin, dopamine and norepinephrine that are primarily involved in regulating and mood alleviating mood. Despite the availability of large number of drugs, many of patients are resistant to the current mode of treatment that are available now adays. The obstacle that is significant for the transportation of beneficial therapeutic entities to the nervous system is BBB that is the blood brain barrier. There are junctions that are present in the endothelial cells of the blood brain barrier that stop the drugs passage. Now nanoparticles are receiving significant limelight owing to their small size and efficient brain targeting activity, making them likely to cross the blood brain barrier while carrying the intact drug molecule otherwise incapable of permeation. In this study the fluoxetine loaded liposomal nanoparticle coated with PEG were developed to transport the drug across the BBB to the central nervous system having much greater efficiency. For testing its delivery, the animal that is mice model of depression is used with the specific name that is designed in order to induce depression like symptoms in mice. Before and After treatment great differences between the physical behaviors like Elevated maze, open field test, force swim test etc and sucrose consumption test were identified and plotted, as liposomes that having capabilities to carry the anti-depressant drug molecule that is administered through the Oral route of administration or the better and improved method of treatment. 30cm.

Place Hold on Oral Administration of Fluoxetine Incorporated Liposomal Nanoparticles coated with PEG in Treatment of Chronic Mild stress (CMS) /

Characterization of atrial natriuretic peptide (ANP) response in depression-induced mice models /

By Ali, Saman . . 71p. , Depression is a complex psychological disorder that is also often link to the hormonal imbalances. Our research delves into the intricate relationship between depression and atrial Natriuretic Peptide (ANP), considering the multifaceted influences of neurological, genetic, and environmental factors. With a focus on hormonal imbalances as key contributors to depression, our investigation explores the potential therapeutic effects of Levothyroxine (LT4) in the context of ANP. Utilizing an early weaning mouse model involving maternal separation, we conducted a detailed examination of the anxiolytic effects of LT4, aiming to evaluate its efficacy in alleviating symptoms associated with anxiety and depression. Behavioral assessments and histological analyses were employed to comprehensively evaluate the impact of LT4 on ANP. This study also extends to molecular investigations using RT-PCR to analyze the distribution and expression of ANP within the mouse central nervous system, highlighting the cortex region. Our findings reveal significant differences in brain expression levels of ANP between treated mice and those exhibiting depressive symptoms. This insight suggests potential therapeutic applications of ANP for mitigating depression, presenting intriguing avenues for further research, particularly in the context of depression-induced mouse models through parental separation. This research contributes to an enriched understanding of the complex factors influencing depression and proposes interventions that extend beyond conventional approaches. The integration of behavioral assessments, histological analyses, and molecular investigations offers a holistic perspective, laying the groundwork for future exploration in the critical realm of mental health research. 30cm.

Place Hold on Characterization of atrial natriuretic peptide (ANP) response in depression-induced mice models /

Nelson essentials of pediatrics /

. xv, 829 pages; 29 cm.. 9780323775632 | 9780323775625

Place Hold on Nelson essentials of pediatrics /